2024. Anti-CD20 Therapy and Disability Progression in Relapsing Multiple Sclerosis. Current Research in Neurology and Neurosurgery. 7, 1 (Jul. 2024), 17–24. DOI:https://doi.org/10.5281/zenodo.22310428.